Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 19, 2025 11:17 ET | Source: Research and Markets

Chronic Obstructive Pulmonary Disease (COPD) Seven-Market Drug Forecast and Market Analysis Report 2023-2025 & 2025-2033

Dublin, May 19, 2025 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD): Seven-Market Drug Forecast and Market Analysis - Update (2025)" has been added to ...
October 11, 2024 06:35 ET | Source: Research and Markets

COPD Seven (US, France, Germany, Italy, Spain, UK, Japan) Drug Market Analysis & Forecasts 2024: Sales to Reach $30.8 Billion in 2033 - GSK, AstraZeneca, and Sanofi/Regeneron Compete for First Place

Dublin, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The "COPD: Seven-Market Drug Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering.This report covers the 7MM (US,...
September 13, 2024 06:56 ET | Source: Research and Markets

Chronic Obstructive Pulmonary Disease (COPD) Epidemiology Forecast to 2033: Focus on US, France, Germany, Italy, Spain, UK, and Japan

Dublin, Sept. 13, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD): Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. In the...
January 25, 2024 08:19 ET | Source: Research and Markets

Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, 2023: High-Level Data, Leading Companies, Trial Outcomes, Enrollment Trends, and Latest Developments

Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023" report has been added to ResearchAndMarkets.com's offering. This...
August 31, 2023 06:24 ET | Source: Research and Markets

Global Chronic Obstructive Pulmonary Disease Therapeutics Market 2023-2028: AstraZeneca, Boehringer Ingelheim, and Novartis Spearhead Advancements

Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Therapeutics Market (2023-2028) by Drug Type, Distribution Channel, and Geography, Competitive Analysis,...
August 31, 2023 06:22 ET | Source: Research and Markets

Global Chronic Obstructive Pulmonary Disease Therapeutics Market 2023-2028: AstraZeneca, Boehringer Ingelheim, and Novartis Spearhead Advancements

Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Therapeutics Market (2023-2028) by Drug Type, Distribution Channel, and Geography, Competitive Analysis,...
August 31, 2023 06:19 ET | Source: Research and Markets

Global Chronic Obstructive Pulmonary Disease Therapeutics Market 2023-2028: AstraZeneca, Boehringer Ingelheim, and Novartis Spearhead Advancements

Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Therapeutics Market (2023-2028) by Drug Type, Distribution Channel, and Geography, Competitive Analysis,...
January 23, 2023 10:03 ET | Source: Research and Markets

Global Chronic Obstructive Pulmonary Disease (COPD) Market Report 2023 - 2028: Featuring AstraZeneca, Pfizer, GlazoSmithKline and Novartis Among Others

Dublin, Jan. 23, 2023 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD) Market, Global Forecast 2023-2028, Industry Trends, Growth, Insight, Impact of Inflation, Company...